Author:
Zhang Zhenghong,Zhang Yan,Lin Fengping,Wang Zhengchao
Reference51 articles.
1. Wang F, Zhang ZH, Xiao KZ, Wang ZC. Roles of hypothalamic-pituitary-adrenal axis and hypothalamus-pituitary-ovary axis in the abnormal endocrine functions in patients with polycystic ovary syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017;39(5):699-704. DOI: 10.3881/j.issn.1000-503X.2017.05.017
2. Abbott DH, Dumesic DA, Levine JE. Hyperandrogenic origins of polycystic ovary syndrome—Implications for pathophysiology and therapy. Expert Review of Endocrinology and Metabolism. 2019;14(2):131-143. DOI: 10.1080/17446651.2019.1576522
3. Steckler T, Wang J, Bartol FF, Roy SK, Padmanabhan V. Fetal programming: Prenatal testosterone treatment causes intrauterine growth retardation, reduces ovarian reserve and increases ovarian follicular recruitment. Endocrinology. 2005;146(7):3185-3193. DOI: 10.1210/en.2004-1444
4. Gougeon A. Regulation of ovarian follicular development in primates: Facts and hypotheses. Endocrine Reviews. 1996;17(2):121-155. DOI: 10.1210/edrv-17-2-121
5. van Weissenbruch MM, Schoemaker HC, Drexhage HA, Schoemaker J. Pharmaco-dynamics of human menopausal gonadotrophin (HMG) and follicle-stimulating hormone (FSH). The importance of the FSH concentration in initiating follicular growth in polycystic ovary-like disease. Human Reproduction. 1993;8(6):813-821. DOI: 10.1093/oxfordjournals.humrep.a138147
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献